Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,500 shares of Plexus stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $242.41, for a total transaction of $363,615.00. Following the completion of the transaction, the chief executive officer directly owned 64,388 shares of the company’s stock, valued at $15,608,295.08. This trade represents a 2.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Plexus Price Performance
PLXS opened at $246.73 on Friday. The firm has a market cap of $6.60 billion, a price-to-earnings ratio of 36.39 and a beta of 0.89. Plexus Corp. has a fifty-two week low of $132.03 and a fifty-two week high of $307.06. The company’s 50-day moving average price is $252.38 and its 200 day moving average price is $248.57. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its earnings results on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating the consensus estimate of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The company had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. During the same period in the prior year, the company earned $1.64 earnings per share. The business’s revenue was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, sell-side analysts expect that Plexus Corp. will post 7.11 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on PLXS shares. Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Stifel Nicolaus increased their price objective on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Weiss Ratings cut Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, September 9th. Needham & Company LLC restated a “buy” rating and issued a $310.00 target price on shares of Plexus in a research report on Friday, August 14th. Finally, Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $273.00.
View Our Latest Research Report on Plexus
Institutional Investors Weigh In On Plexus
Institutional investors and hedge funds have recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Plexus in the 2nd quarter worth approximately $32,000. Covestor Ltd grew its position in Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock worth $35,000 after buying an additional 162 shares during the last quarter. Kilter Group LLC bought a new position in shares of Plexus in the second quarter valued at $40,000. Allworth Financial LP lifted its position in shares of Plexus by 20.8% during the 4th quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock valued at $44,000 after acquiring an additional 52 shares during the last quarter. Finally, Integrated Wealth Concepts LLC acquired a new stake in shares of Plexus during the 2nd quarter valued at $51,000. 94.45% of the stock is owned by institutional investors and hedge funds.
About Plexus
Plexus Corp. is a global electronics manufacturing services company that designs, manufactures and services products for original equipment manufacturers. The company supports customers across the product life cycle, from product development and engineering to supply chain management, assembly, testing, fulfillment and aftermarket services.
Plexus provides solutions for industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.
See Also
- Five stocks we like better than Plexus
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
